SUSHEN Medicamentos

Ahmedabad, India Founded: 2002 • Age: 24 yrs
Provides project management and drug delivery research for pharmaceuticals globally.

About SUSHEN Medicamentos

SUSHEN Medicamentos is a Healthcare company based in Ahmedabad (India) founded in 2002. It provides project management and drug delivery research for pharmaceuticals globally. It operates on a B2B model. The company has 39 employees. Its Indian entity Sushen Medicamentos Private Limited reported revenue of β‚Ή30.42 Cr. SUSHEN Medicamentos offers products and services including Formulation and Development, Project Management Services, and Drug Delivery Research. Its focus areas include Pharmaceuticals, Drug Development, Research and Development and Manufacturing.

Company details

Sushen Medicamentos Pvt. Ltd. is a global provider of end-to-end pharmaceutical services, specializing in project management, drug delivery research, and product development. They deliver innovative formulation solutions to enhance bioavailability and achieve bio-equivalence, while offering turnkey solutions from plant design to commissioning. Based in Ahmedabad, India, they serve pharmaceutical and biotechnology companies worldwide with a focus on quality and integrity.

  • Headquarters Ahmedabad, India
  • Employees 39
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website sushenmed.com
  • Legal Name Sushen Medicamentos Pvt. Ltd.
  • Date of Incorporation 17 Oct, 2001
  • Jurisdiction Ahmedabad, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹30.42 Cr

    FY 2025 · +1% YoY

  • Net Profit
    ₹67 Lakh

    FY 2025 · 2% margin

  • EBITDA
    ₹3.41 Cr

    FY 2025 · 11% margin

  • Employee Count
    39

Products & Services of SUSHEN Medicamentos

SUSHEN Medicamentos offers a comprehensive portfolio of products and services, including Formulation and Development, Project Management Services, and Drug Delivery Research.

Formulation and Development
Drug Development

Improves bioavailability and achieves bio-equivalence in pharmaceuticals

Project Management Services
Consulting

Manages end-to-end pharmaceutical projects from concept to commissioning

Drug Delivery Research
Research

Focuses on innovative drug delivery methods for product enhancement

Board of directors of Sushen Medicamentos Private Limited (SUSHEN Medicamentos)

Sushen Medicamentos Private Limited is the primary company behind SUSHEN Medicamentos. The boards of the 2 registered companies of SUSHEN Medicamentos currently have 3 directors; the longest-serving is Kaushik Kantilal Shah, appointed in 2021. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kaushik Kantilal Shah
DIN 00276004
Designated Partner01 May 20215 yrs 6 moQuadbiogen Llp, Sushen Medicamentos Private Limited
Aman Kulabkar
DIN 06998800
Director01 May 20215 yrs 6 moSushen Medicamentos Private Limited
Venkatram Bakthavatchalam
DIN 06856800
Designated Partner23 Nov 20214 yrs 11 moQuadbiogen Llp

Financials of SUSHEN Medicamentos

Figures of Sushen Medicamentos Private Limited, the primary company behind SUSHEN Medicamentos, for FY 2025. Revenue was ₹30.42 Cr (+1% year on year). Net profit was ₹67 Lakh (2% margin). EBITDA was ₹3.41 Cr (11% margin). Revenue has grown at a compounded annual rate of +27% over three years and +19% over five years.

  • ₹30.42 CrRevenue · FY 2025 · +1% YoY
  • ₹67 LakhNet profit · 2% margin
  • ₹3.41 CrEBITDA · 11% margin
  • ₹2.88 CrPaid-up capital
  • 39Employees (provident fund records)
  • +27%Revenue CAGR, 3 years
  • +19%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sushen Medicamentos Private Limited are on its company page.

Premium access

Detailed financial statements for SUSHEN Medicamentos

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sushen Medicamentos

Premium access

Complete news archive for SUSHEN Medicamentos

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SUSHEN Medicamentos

SUSHEN Medicamentos was founded in 2002.

SUSHEN Medicamentos is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

SUSHEN Medicamentos has 39 employees.

The primary company behind SUSHEN Medicamentos, Sushen Medicamentos Private Limited, reported revenue of β‚Ή30.42 Cr for FY 2025, up 1% year on year.

Sushen Medicamentos Pvt. Ltd. is a global provider of end-to-end pharmaceutical services, specializing in project management, drug delivery research, and product development. They deliver innovative formulation solutions to enhance bioavailability and achieve bio-equivalence, while offering turnkey solutions from plant design to commissioning. Based in Ahmedabad, India, they serve pharmaceutical and biotechnology companies worldwide with a focus on quality and integrity.

SUSHEN Medicamentos offers Formulation and Development, Project Management Services, and Drug Delivery Research.

SUSHEN Medicamentos is associated with 2 legal entities: Sushen Medicamentos Private Limited, Quadbiogen Llp.

The legal entities of SUSHEN Medicamentos currently have 3 directors, including Venkatram Bakthavatchalam, Kaushik Kantilal Shah, Aman Kulabkar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available